MIB: Medical Innovation Boutique
Healthcare’s Next Breakthroughs.
An exclusive investment club granting investors access to a portfolio of early-stage medical innovations.
Rigorous Assessment
We embed expertise to minimize uncertainty and maximize potential.
Clinical Validation:
Investment decisions are backed by an Advisory Board of prominent physicians who are the end-users and leaders in their fields.
Meticulous Vetting by Experts
We implement a multi-stage screening process, involving expert review panels, to identify the most promising opportunities.
Deal Flow & Ecosystem Access
We source high-quality startups through collaborations with medical research institutions, incubators, and accelerators.
Proprietary Technology Sourcing
Our search includes leveraging advanced defense technologies and repurposing them to create groundbreaking medical innovations.
Focused Investment Thesis
Our strategy focuses on early-stage companies (Medical Devices, Diagnostics, and Digital Health) in Seed and Series A funding rounds.
About MIB
MIB (Medical Innovation Boutique) is led by senior executives and leading physicians from Israel’s world‑class health ecosystem.
MIB connects visionary investors with breakthrough medical innovations, including early‑stage life‑science ventures, medical devices, diagnostics, digital health solutions, and repurposed advanced defense technologies adapted into multi‑purpose medical applications.
All portfolio startups undergo a rigorous multi‑stage screening process and are validated by leading physicians from Israel’s top hospitals, ensuring genuine medical need and strong scientific credibility.
Members can selectively invest in any of the high‑potential portfolio startups sourced through partnerships with Israel’s premier hospitals, research centers, and innovation hubs.
A portiaon of revenues supports cutting‑edge cancer early‑detection research, aligning financial returns with meaningful healthcare impact.
The Advisory Board
Every investment is scrutinized by leaders who direct major departments at Israel’s top medical centers, ensuring the highest level of clinical and market alignment.
The Impact with Multiplier
Delivering Global Good:
Backing transformative products that aim to make healthcare more accurate and accessible.
Dedicated Cancer Research Funding:
A portion of MiB's revenues supports research in the early detection of cancer.
Why to Invest in ISRAEL?
We believe in Doing Good while Investing Smart.
Portfolio Focus: Diverse Areas of Opportunity
We seek opportunities across the health-tech spectrum, providing a diverse portfolio for our investors.
Key areas represented in our pipeline:
Digital Health & AI Data Diagnostics
AI platforms for decision support (e.g., Diabetes Management) and next-generation point-of-care diagnostics (e.g ., Vaginitis Diagnostics).
Neurovascular & Stroke Intervention
Creating high-performance, minimally invasive devices for cerebral thrombectomy and stroke treatment (e.g., Aspiration Catheters, Carotid Access Systems).
Structural Heart & Interventional Cardiology:
Focusing on advanced transcatheter valve replacement systems with native tissue preservation (e.g., Tricuspid Valve Repair).
Non-invasive Diagnostics
Screening tools that provide non-invasive alternatives for early detection of complex diseases (e.g., Colorectal Cancer Screening).
Specialized Therapeutics
Development of highly targeted pharmaceutical solutions for core symptoms of chronic conditions (e.g., Autism Therapeutics).
Make it happen with MIB
MiB extends a varied portfolio to investors who wish to make targeted, impactful investments in the life science sector—partner with us to gain exclusive access to innovations that are clinically validated and poised for financial and health-promoting benefits. strategically aligned for strong financial outcomes and improved healthcare impact.
Connect with us to receive our full investment deck and explore current funding opportunities.